Study of SA+X in the Treatment of Newly Diagnosed AML | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of SA+X in the Treatment of Newly Diagnosed AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2026-07-30		NCT07548710

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese People's Liberation Army No 455 Hospital	2
Huadong Hospital	23
Ruijin Hospital	454
Shanghai 7th People's Hospital	8
Shanghai Fengxian District Central Hospital	3
Shanghai Jiahui International Hospital	1
Shanghai Municipal Hospital of Traditional Chinese Medicine	11
Shanghai Tong Ren Hospital	14
The First Hospital of Jilin University	154
The First People's Hospital of Yunnan	30
Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai	6

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai	Shanghai	China	1